Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sonoma Pharmaceuticals (SNOA) Free Cash Flow (2016 - 2023)

Sonoma Pharmaceuticals (SNOA) has 4 years of Free Cash Flow data on record, last reported at -$1.2 million in Q1 2013.

  • For Q1 2013, Free Cash Flow rose 25.38% year-over-year to -$1.2 million; the TTM value through Mar 2013 reached $893000.0, up 120.44%, while the annual FY2025 figure was -$168000.0, 93.0% up from the prior year.
  • Free Cash Flow reached -$1.2 million in Q1 2013 per SNOA's latest filing, down from -$1.2 million in the prior quarter.
  • Across five years, Free Cash Flow topped out at $4.5 million in Q3 2012 and bottomed at -$1.6 million in Q4 2010.
  • Average Free Cash Flow over 4 years is -$664333.3, with a median of -$1.2 million recorded in 2011.
  • The widest YoY moves for Free Cash Flow: up 559.24% in 2012, down 2178.26% in 2012.
  • A 4-year view of Free Cash Flow shows it stood at -$1.6 million in 2010, then rose by 25.38% to -$1.2 million in 2011, then increased by 5.06% to -$1.2 million in 2012, then fell by 0.77% to -$1.2 million in 2013.
  • Per Business Quant database, its latest 3 readings for Free Cash Flow were -$1.2 million in Q1 2013, -$1.2 million in Q4 2012, and $4.5 million in Q3 2012.